SINGAPORE, April 26 (Bernama-GLOBE NEWSWIRE) — Claritas HealthTech Pte. Ltd. (“Claritas”), a healthcare technology company specializing in innovative deep-learning, image enhancement and accelerated image acquisition to improve the efficiency of medical imaging, announces today it has finalized a license agreement to commercialise the Paediatric MRI software developed and patented by the University of North Carolina (UNC) at Chapel Hill. This license agreement grants Claritas the exclusive worldwide right to promote and market the deep-learning software solution that improves the quality and efficiency of paediatric MRI scans through Retrospective Artifact Correction.
“MRI scans are particularly sensitive to physical movement and for a child to remain motionless for up to an hour to obtain an image of appropriate quality is difficult. The thought of spending forty-five minutes to an hour in a noisy, enclosed tube can be intimidating for adults. Sometimes a child may have to take sedation or undergo a general anaesthetic which brings additional risk and requires close supervision. This can add delay and limit the use of a valuable tool,” commented Dr Arup Paul, Chief Clinical Strategy Officer, at Claritas HealthTech.
